Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
World Journal of Experimental Medicine
|
March 2, 2016
Hepatocellular carcinoma: Where are we?
Roberto Mazzanti, Umberto Arena, Renato Tassi
Clinical Genitourinary Cancer
|
December 3, 2014
Hyperlipidemia and hypothyroidism among metastatic renal cell carcinoma patients taking sunitinib malate. Related or unrelated adverse events?
Renato Tassi, Valentina Baldazzi, Alberto Lapini, et al.
Urologic Oncology
|
October 2, 2010
The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: a prospective single-center study
Valentina Baldazzi, Renato Tassi, Alberto Lapini, et al.
Future Medicinal Chemistry
|
August 22, 2015
Emerging drugs in refractory colorectal cancer
Stefania Nobili, Alessandro Galletta, Marco Brugia, et al.
Cancer
|
September 30, 2011
Sunitinib-induced hyperparathyroidism: a possible mechanism to altered bone homeostasis
Valentina Baldazzi, Renato Tassi, Alberto Lapini, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 2, 2012
Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: a single-center experience with 31 patients
Bruno Neri, Agnese Vannini, Marco Brugia, et al.
Oncology Research
|
March 9, 2018
ERRATUM
Enrico Mini, Ida Landini, Laura Lucarini, et al.
Oncology Research
|
April 22, 2017
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways
Enrico Mini, Ida Landini, Laura Lucarini, et al.
Oncology Research
|
December 7, 2019
Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution Experience
Stefania Nobili, Daniele Lavacchi, Gabriele Perrone, et al.
International Journal of Cancer
|
April 12, 2019
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
Enrico Mini, Andrea Lapucci, Gabriele Perrone, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
World Journal of Experimental Medicine
|
March 2, 2016
Hepatocellular carcinoma: Where are we?
Roberto Mazzanti, Umberto Arena, Renato Tassi
Clinical Genitourinary Cancer
|
December 3, 2014
Hyperlipidemia and hypothyroidism among metastatic renal cell carcinoma patients taking sunitinib malate. Related or unrelated adverse events?
Renato Tassi, Valentina Baldazzi, Alberto Lapini, et al.
Urologic Oncology
|
October 2, 2010
The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: a prospective single-center study
Valentina Baldazzi, Renato Tassi, Alberto Lapini, et al.
Future Medicinal Chemistry
|
August 22, 2015
Emerging drugs in refractory colorectal cancer
Stefania Nobili, Alessandro Galletta, Marco Brugia, et al.
Cancer
|
September 30, 2011
Sunitinib-induced hyperparathyroidism: a possible mechanism to altered bone homeostasis
Valentina Baldazzi, Renato Tassi, Alberto Lapini, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 2, 2012
Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: a single-center experience with 31 patients
Bruno Neri, Agnese Vannini, Marco Brugia, et al.
Oncology Research
|
March 9, 2018
ERRATUM
Enrico Mini, Ida Landini, Laura Lucarini, et al.
Oncology Research
|
April 22, 2017
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways
Enrico Mini, Ida Landini, Laura Lucarini, et al.
Oncology Research
|
December 7, 2019
Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution Experience
Stefania Nobili, Daniele Lavacchi, Gabriele Perrone, et al.
International Journal of Cancer
|
April 12, 2019
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
Enrico Mini, Andrea Lapucci, Gabriele Perrone, et al.
Page
of 2